US loss of exclusivity · Cardiometabolic

Zepbound

Eli Lilly

2036US generics from
2025Today: 20262037
2025 worldwide sales
$13.5B
Date basis
Company guidance
US generics
Filed with the FDA
Pharma Patent Cliff by readouts.io Data checked 24 October 2026 · Full Zepbound timeline →